Morten H. Bestle

ORCID: 0000-0001-6585-2659
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sepsis Diagnosis and Treatment
  • Hemodynamic Monitoring and Therapy
  • Intensive Care Unit Cognitive Disorders
  • Respiratory Support and Mechanisms
  • Cardiac Arrest and Resuscitation
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • COVID-19 Clinical Research Studies
  • Acute Kidney Injury Research
  • Electrolyte and hormonal disorders
  • Long-Term Effects of COVID-19
  • Renal function and acid-base balance
  • Nosocomial Infections in ICU
  • Thermal Regulation in Medicine
  • Cardiac, Anesthesia and Surgical Outcomes
  • Family and Patient Care in Intensive Care Units
  • Anesthesia and Neurotoxicity Research
  • Muscle and Compartmental Disorders
  • Anesthesia and Sedative Agents
  • Pneumonia and Respiratory Infections
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Emergency and Acute Care Studies
  • Blood transfusion and management
  • Platelet Disorders and Treatments
  • Health, psychology, and well-being
  • Thermoregulation and physiological responses

University of Copenhagen
2016-2025

Zealand University Hospital
2013-2025

Copenhagen University Hospital
2012-2025

Centre for Research in Intensive Care
2019-2024

Rigshospitalet
2012-2024

Nordsjællands Hospital
2014-2023

Glostrup Hospital
2019-2023

Peking University People's Hospital
2023

Peking University
2023

Stavanger University Hospital
2022

Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established patients with severe sepsis.In this multicenter, parallel-group, blinded trial, we randomly assigned sepsis to the ICU either 6% HES 130/0.42 (Tetraspan) or Ringer's acetate at a dose of up 33 ml per kilogram ideal body weight day. The primary outcome measure was death end-stage kidney failure (dependence on dialysis) 90 days after...

10.1056/nejmoa1204242 article EN New England Journal of Medicine 2012-06-27

<h3>Abstract</h3> Micro-CT is a powerful tool to analyze and visualize the internal morphology of human permanent teeth. It increasingly used for investigation epidemiological questions provide dentist with necessary information required successful endodontic treatment. The aim present paper was propose an image processing method automate parts work needed fully describe One hundred four teeth were scanned on high-resolution micro-CT using automatic specimen changer. Python code in Jupyter...

10.1136/bmj.332.7556.1482 article EN BMJ 2006-06-22

For patients in intensive care units, sepsis is a common and potentially deadly complication prompt initiation of appropriate antimicrobial therapy improves prognosis. The objective this trial was to determine whether strategy spectrum escalation, guided by daily measurements the biomarker procalcitonin, could reduce time therapy, thus improving survival.Randomized controlled open-label trial.Nine multidisciplinary units across Denmark.A total 1,200 critically ill were included after meeting...

10.1097/ccm.0b013e31821e8791 article EN Critical Care Medicine 2011-05-13

Prophylaxis for gastrointestinal stress ulceration is frequently given to patients in the intensive care unit (ICU), but its risks and benefits are unclear.In this European, multicenter, parallel-group, blinded trial, we randomly assigned adults who had been admitted ICU an acute condition (i.e., unplanned admission) were at risk bleeding receive 40 mg of intravenous pantoprazole (a proton-pump inhibitor) or placebo daily during stay. The primary outcome was death by 90 days after...

10.1056/nejmoa1714919 article EN New England Journal of Medicine 2018-10-24

Patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) are treated supplemental oxygen, but benefits and harms of different oxygenation targets unclear. We hypothesized that using a lower target for partial pressure arterial oxygen (Pao2) would result mortality than higher target.

10.1056/nejmoa2032510 article EN New England Journal of Medicine 2021-01-20

Intravenous fluids are recommended for the treatment of patients who in septic shock, but higher fluid volumes have been associated with harm intensive care unit (ICU).In this international, randomized trial, we assigned shock ICU had received at least 1 liter intravenous to receive restricted or standard therapy; were included if onset within 12 hours before screening. The primary outcome was death from any cause 90 days after randomization.We enrolled 1554 patients; 770 restrictive-fluid...

10.1056/nejmoa2202707 article EN New England Journal of Medicine 2022-06-17

We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia the international, randomised, blinded COVID STEROID 2 trial. In primary, conventional analyses, predefined statistical significance thresholds were not reached. conducted a pre-planned Bayesian analysis facilitate probabilistic interpretation. analysed outcome data within 90 intention-to-treat population (data available 967 982 patients) using models...

10.1007/s00134-021-06573-1 article EN other-oa Intensive Care Medicine 2021-11-10
Peter Pickkers Derek C. Angus Kristie Bass Rinaldo Bellomo Erik van den Berg and 95 more Juliane Bernholz Morten H. Bestle Kent Doi Chistopher J. Doig Ricard Ferrer Bruno François Henrik Gammelager U. G. Pedersen Eric A. J. Hoste Susanne Iversen Michael Joannidis John A. Kellum Kathleen D. Liu Melanie Meersch Ravindra L. Mehta Scott J. Millington Patrick Murray Alistair Nichol Marlies Ostermann Ville Pettilä Christoffer Sølling Matthias Winkel Paul J. Young Alexander Zarbock Angus Carter D Friès Philip Eller Ludovic Gérard Nicolas DeSchryver Elisabeth Diltoer Vincent Huberlant Isabelle Michaux Patrick M. Honorè Tom Fivez Christopher J. Doig Gordon Wood J. Gordon Boyd Alexis F. Turgeon Maj K. Kamper Thomas Strøm Sussanne Iversen Hendrik Gammelager Bodil Steen Rasmussen Christoffer Sølling Morten Hyllander Mæller Thorbjoern Groefte Nilanjan Dey Ulf Gøttrup Pedersen Mila Valkonen Panu Uusalo Ville Jalkanen Ferhat Meziani Jermie Lemarie Gaëtan Plantefève Konstantimos Bachoumas Jean Louis Dufour Anne-Laure Fedou Pierre Asfar Xavier Monnet Christophe Vinsonneau Sébastien Gibot Christophe Guitton Jean‐Pierre Quenot Grégoire Müller Jean Yves Lefrant Emmanuelle Mercier Alexandre Mebazaa Andreas Kortgen Sebastian Fichtner Stefan Kluge Gernot Marx Ignatio Martin-Loeches Bairbre McNicolas Hidenobu Kamohara Masahiro Harada Takuo Nakagami Shingo Adachi Kohei Ota Ryo Furuya Ayumu Tsuruoka Yasuaki Mizushima Satoki Inoue Pieter R. Tuinman F Wim Roozendaal Bert Beishuizen Oscar Hoiting Tom Dormans Arthur R. H. van Zanten Paul J. Young Anthony P. Williams Colin McArthur Paweł Twardowski Shay McGuinness Ricard Ferrer Carol Lorencio Cardenas

Ilofotase alfa is a human recombinant alkaline phosphatase with reno-protective effects that showed improved survival and reduced Major Adverse Kidney Events by 90 days (MAKE90) in sepsis-associated acute kidney injury (SA-AKI) patients. REVIVAL, was phase-3 trial conducted to confirm its efficacy safety. In this international double-blinded randomized-controlled trial, SA-AKI patients were enrolled < 72 h on vasopressor 24 of AKI. The primary endpoint 28-day all-cause mortality. main...

10.1007/s00134-023-07271-w article EN cc-by-nc Intensive Care Medicine 2024-01-01

Importance Supplemental oxygen is ubiquitously used in patients with COVID-19 and severe hypoxemia, but a lower dose may be beneficial. Objective To assess the effects of targeting Pa o 2 60 mm Hg vs 90 hypoxemia intensive care unit (ICU). Design, Setting, Participants Multicenter randomized clinical trial including 726 adults receiving at least 10 L/min or mechanical ventilation 11 ICUs Europe from August 2020 to March 2023. The was prematurely stopped prior outcome assessment due slow...

10.1001/jama.2024.2934 article EN JAMA 2024-03-19

Norepinephrine, the first-line vasopressor for septic shock, is not always effective and has important catecholaminergic adverse effects. Selepressin, a selective vasopressin V1a receptor agonist, noncatecholaminergic that may mitigate sepsis-induced vasodilatation, vascular leakage, edema, with fewer To test whether selepressin improves outcome in shock. An adaptive phase 2b/3 randomized clinical trial comprising 2 parts included adult patients (n = 868) shock requiring more than 5 μg/min...

10.1001/jama.2019.14607 article EN JAMA 2019-10-02
Jorinde Raasveld Sanne de Bruin Merijn C. Reuland Claudia van den Oord Jimmy Schenk and 95 more Cécile Aubron Jan Bakker Maurizio Cecconi Aarne Feldheiser Jens Meier Marcella C.A. Müller Thomas Scheeren Zoe McQuilten Andrew Flint Tarikul Hamid Michaël Piagnerelli Tina Tomić Mahečić Jan Benes Lene Russell Hernán Aguirre-Bermeo Konstantina Triantafyllopoulou Vasiliki Chantziara Mohan Gurjar Sheila Nainan Myatra Vincenzo Pota Muhammed Elhadi Ryszard Gawda Mafalda Mourisco Marcus D. Lancé Vojislava Nešković Matej Podbregar Juan V. Llau Manual Quintana‐Diaz Maria Cronhjort Carmen A. Pfortmueller Nihan Yapící Nathan D. Nielsen Akshay Shah Harm‐Jan de Grooth Alexander P. J. Vlaar Alisa M. Higgins Ary Serpa Neto Karina Brady Erica M. Wood Alexis Poole Tony Trapani Meredith Young D. James Cooper Paul Secombe Graham Reece Prashanti Marella David Brewster Alan Rashid Ruwan Suwandarathne Raman Azad Jonathan Barrett Elisha Turner Amber‐Louise Poulter Lixian Chen Vishwanath Biradar Christina Whitehead Sandra Peake Alexis Tabah Stephanie O’Connor Michael C. Reade Guido Janssen Richard McAllister Katherine Elizabeth Triplett David Bowen Hergen Buscher John P. Santamaria Dinesh Parmar Paul Power Craig French Matthew Mac Partlin Md Motiul Islam Injamam Ull Haque A. de Anta Román Lionel Haentjens Višnja Ikić Slavica Kvolik Robert Bojčić Kazimir Juričić Martin Duksa Lukáš Bílek I Satinský Jan Zatloukal Lene Russell Morten H. Bestle Christian S. Meyhoff Ana Maria Diaz-Medina Verónica Llumiquinga Hernán Aguirre-Bermeo Heinert Enmanuel Gonzabay-Campos Mohamed Elbahnasawy Xavier Chapalain Charlène Le Moal Pierre-Yves Egreteau Yoann Launey Florian Reizine

Importance Red blood cell (RBC) transfusion is common among patients admitted to the intensive care unit (ICU). Despite multiple randomized clinical trials of hemoglobin (Hb) thresholds for transfusion, little known about how these are incorporated into current practice. Objective To evaluate and describe ICU RBC practices worldwide. Design, Setting, Participants International, prospective, cohort study that involved 3643 adult from 233 ICUs in 30 countries on 6 continents March 2019 October...

10.1001/jama.2023.20737 article EN JAMA 2023-10-12

To assess the incidence, risk factors, and outcomes of atrial fibrillation (AF) in ICU to describe current practice management AF.Multicenter, prospective, inception cohort study.Forty-four ICUs 12 countries four geographical regions.Adult, acutely admitted patients without a history persistent/permanent AF or recent cardiac surgery were enrolled; periods from October 2020 June 2021.None.We included 1,423 analyzed 1,415 (99.4%), among whom 221 had 539 episodes AF. Most (59%) diagnosed with...

10.1097/ccm.0000000000005883 article EN Critical Care Medicine 2023-04-20

To explore whether a strategy of more intensive antibiotic therapy leads to emergence or prolongation renal failure in care patients.Secondary analysis from randomised trial (the Procalcitonin And Survival Study). The arms were conserved the primary for main analysis.Nine mixed surgical/medical units across Denmark.1200 adult patients, 18+ years, expected stay +24 h.bilirubin >40 mg/dl, triglycerides >1000 increased risk blood sampling, pregnant/breast feeding and psychiatric...

10.1136/bmjopen-2011-000635 article EN cc-by-nc BMJ Open 2012-01-01
Theis Skovsgaard Itenov Maria Egede Johansen Morten H. Bestle Katrín Þormar Lars Hein and 95 more Louise Gyldensted Anne Lindhardt Henrik Christensen Stine Estrup Henrik Planck Pedersen Matthew B.A. Harmon Uday Kant Soni Silvia Perez-Protto Nicolai Wesche Ulrik Skram John Asger Petersen Thomas Mohr Tina Waldau Lone Musaeus Poulsen Ditte Gry Strange Nicole P. Juffermans Daniel I. Sessler Else Tønnesen Kirsten Møller Dennis Karsten Kristensen Alessandro Cozzi‐Lepri Jens Lundgren Jens‐Ulrik Stæhr Jensen Jens‐Ulrik Stæhr Jensen Theis Skovsgaard Itenov Maria Egede Johansen Jens Lundgren Else Tønnesen Morten H. Bestle Anne Lindhardt Henrik Christensen Henrik Planck Pedersen Lone Musaeus Poulsen Alessandro Cozzi‐Lepri Susanne Illkjær Uday Kant Soni Kirsten Møller Nicole P. Juffermans Daniel I. Sessler Thomas Mohr Henry Masur Christian Torp‐Pedersen Andrew Copas Birgit Riis Nielsen Dennis Karsten Kristensen Jesper Grarup Jette G. Hansen Kim G. Nielsen Lone Valbjørn Sanne Lauritzen Tina Kold Kathrine Grundahl Lars Hein Rikke Hein Rasmussen Nikolaj Wesche Hasse Blom Peer Eske Jensen Tina Galle Bente Thaarslund Camilla Skandov Iben Langholz Ulrik Skram R. E. Berthelsen Dorthe Kjær Merete Uldbjerg Lily Lipsius Louise Gyldensted Magaly Engsig Rikke Helsted Birgitte Dissing Andersen Eigil Nygaard Søren Strande Aimal Khan Bangash Tina Waldau Peter Søe‐Jensen Hamid Tousi Malene Tangager Daniel Hägi‐Pedersen Rainer Gatz Marte Kaasen Engen Christian Åge Wamberg Bo Westergaard Matthew B.A. Harmon Katrín Þormar Stine Stoktoft Rebecca Scherwin Finn Østergård Bærentzen Marlene Mauson Pankoke Lauritzen Frank Pott Christina Bruun Christian S. Meyhoff Ditte Gry Strange Dorthe Fris Palmqvist Claus Hemmingsen Rune Gärtner

10.1016/s2213-2600(18)30004-3 article EN The Lancet Respiratory Medicine 2018-01-08

Background In the early phase of pandemic, some guidelines recommended use corticosteroids for critically ill patients with COVID‐19, whereas others against despite lack firm evidence either benefit or harm. COVID STEROID trial, we aimed to assess effects low‐dose hydrocortisone on patient‐centred outcomes in adults COVID‐19 and severe hypoxia. Methods this multicentre, parallel‐group, placebo‐controlled, blinded, centrally randomised, stratified clinical randomly assigned confirmed hypoxia...

10.1111/aas.13941 article EN Acta Anaesthesiologica Scandinavica 2021-06-17
Carl Thomas Anthon Frédéric Pène Anders Perner Élie Azoulay Kathryn Puxty and 95 more Andry Van de Louw Andreas Barratt‐Due Sanjay Chawla Pedro Castro Pedro Póvoa Luís Coelho Victoria Metaxa Matthias Kochanek Tobias Liebregts Thomas Kander Johanna Hästbacka Jo Bønding Andreasen Edwige Péju Lene Bjerregaard Nielsen Christine Lodberg Hvas E. Dufranc Emmanuel Canet Linda Lundqvist C. Wright Julien Schmidt Fabrice Uhel Hafid Ait‐Oufella Mette Krag E. Badia Cándido Díaz‐Lagares Sophie Menat Guillaume Voiriot Niels Clausen Kristian Lorentzen Reidar Kvåle Thomas Hildebrandt Aleksander Rygh Holten Kristian Strand Asterios Tzalavras Morten H. Bestle Pål Klepstad Sara González Fernández Damien Vimpére Maria Carolina Paulino Carina Graça Catherina Lueck Christian Svendsen Juhl Carolina Cabral Pereira da Costa Per Martin Bådstøløkken Teresa Miranda Lia Susana Aires Lêdo João Torres Anders Granholm Morten Hylander Møller Lene Russell Ahmed Abdelhady A. Khalil Ahmed Yehia Haney Salem Hesham Farahat Manu Sudevan Melissa Biggart Nirmeen Fatima Mohammed Elkhonezy Anne‐Marie Gellert Bunzel Rine M. Siegumfeldt Stine Rom Vestergaard Juliette Pelle Minh-Pierre Lê Clara Vigneron Morgane Bertrix P Cirera Driss Laghlam Swann Bredin Nathalie Marin Maria Dietz Toppenberg Brice Benelli Amélie Séguin Charlotte Garret Florian Guillotin Gauthier Blonz Jean-Baptiste Lascarrou Jérémie Lemarie Luc Desmedt Maïté Agbakou Mathieu Carpentier Maëlle Martin Naïla Benkalfate Olivier Zambon Paul Decamps Pauline L. Wilquin Soraya Benguerfi John A. Gardner Natalie Remor Sheila Carr Gloria Yang Coralie Gernez Ingrid Thiry Louaï Missri Moritz K. G. Denneborg Katherine Brown

Thrombocytopenia (platelet count < 150 × 109/L) is common in intensive care unit (ICU) patients and likely associated with worse outcomes. In this study we present international contemporary data on thrombocytopenia ICU patients. We conducted a prospective cohort adult 52 ICUs across 10 countries. assessed frequencies of thrombocytopenia, use platelet transfusions clinical outcomes including mortality. evaluated pre-selected potential risk factors for the development during stay associations...

10.1007/s00134-023-07225-2 article EN cc-by-nc Intensive Care Medicine 2023-10-09
Coming Soon ...